Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana-Reference-Cited by-同舟云学术

Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana

Published:2019-11 Issue:11 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Musset Lise¹,Heugas Christophe¹²,Naldjinan Richard³,Blanchet Denis⁴,Houze Pascal⁵,Abboud Philippe³,Volney Béatrice¹,Walter Gaëlle³,Lazrek Yassamine¹,Epelboin Loïc³,Pelleau Stephane¹,Ringwald Pascal⁶,Legrand Eric⁷,Demar Magalie³⁴,Djossou Félix³

Affiliation:

1. Laboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France

2. Faculty of Medicine, Université de Poitiers, Poitiers, France

3. Department of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France

4. Laboratoire Hospitalo-Universitaire de Parasitologie et Mycologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France

5. Biochemistry Laboratory, Hôpital Saint Louis, Paris, France

6. Global Malaria Programme, World Health Organization, Geneva, Switzerland

7. Malaria Genetic and Resistance Group, Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France

Abstract

In South America, Plasmodium vivax resistance to chloroquine was recently reported in Brazil and Bolivia. The objective of this study was to collect data on chloroquine resistance in French Guiana by associating a retrospective evaluation of therapeutic efficacy with an analysis of recurrent parasitemia from any patients. Patients with P. vivax infection, confirmed by microscopy and a body temperature of ≥37.5°C, were retrospectively identified at Cayenne Hospital between 2009 and 2015.

Funder

Santé Publique France

Investissement d'avenir ANR

ARS Guyane

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02116-18

Reference32 articles.

1. WHO. 2018. World malaria report. World Health Organization, Geneva, Switzerland.

2. Substantial increase of malaria in inland areas of eastern French Guiana

3. Malaria on the Guiana Shield: a review of the situation in French Guiana

4. Cellule-interrégionale d’Epidémiologie de Guyane. 2019. Situation du paludisme en Guyane: point du 16 Avril 2019. http://invs.santepubliquefrance.fr/Publications-et-outils/Points-epidemiologiques/Tous-les-numeros/Guyane/2019/Situation-epidemiologique-du-paludisme-en-Guyane.-Point-au-16-avril-2019.

5. WHO. 2015. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Mutations in the crt-o and mdr1 Genes of Plasmodium vivax for the Molecular Surveillance of Chloroquine Resistance in Parasites from Gold Mining Areas in Roraima, Brazil;Microorganisms;2024-08-15

2. Are pvcrt-o and pvmdr1 Gene Mutations Associated with Plasmodium vivax Chloroquine-Resistant Parasites?;Biomedicines;2024-01-09

3. Characteristics of molecular markers associated with chloroquine resistance in Plasmodium vivax strains from vivax malaria cases in Yunnan Province, China;Malaria Journal;2023-06-11

4. Sharp decrease in malaria incidence among the French armed forces in French Guiana;Travel Medicine and Infectious Disease;2023-03

5. About the need to address pediatric health inequalities in French Guiana : a scoping review;Archives de Pédiatrie;2022-07